These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9729456

  • 1. Restricting mobility of Gsalpha relative to the beta2-adrenoceptor enhances adenylate cyclase activity by reducing Gsalpha GTPase activity.
    Wenzel-Seifert K, Lee TW, Seifert R, Kobilka BK.
    Biochem J; 1998 Sep 15; 334 ( Pt 3)(Pt 3):519-24. PubMed ID: 9729456
    [Abstract] [Full Text] [Related]

  • 2. Examining the efficiency of receptor/G-protein coupling with a cleavable beta2-adrenoceptor-gsalpha fusion protein.
    Seifert R, Wenzel-Seifert K, Gether U, Lam VT, Kobilka BK.
    Eur J Biochem; 1999 Mar 15; 260(3):661-6. PubMed ID: 10102993
    [Abstract] [Full Text] [Related]

  • 3. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor.
    Seifert R, Wenzel-Seifert K, Lee TW, Gether U, Sanders-Bush E, Kobilka BK.
    J Biol Chem; 1998 Feb 27; 273(9):5109-16. PubMed ID: 9478963
    [Abstract] [Full Text] [Related]

  • 4. Reconstitution of beta2-adrenoceptor-GTP-binding-protein interaction in Sf9 cells--high coupling efficiency in a beta2-adrenoceptor-G(s alpha) fusion protein.
    Seifert R, Lee TW, Lam VT, Kobilka BK.
    Eur J Biochem; 1998 Jul 15; 255(2):369-82. PubMed ID: 9716378
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The Beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor.
    Seifert R, Wenzel-Seifert K, Lee TW, Gether U, Sanders-Bush E, Kobilka BK.
    J Biol Chem; 1998 May 01; 273(18):5109-16. PubMed ID: 9556548
    [Abstract] [Full Text] [Related]

  • 7. Restricting the mobility of Gs alpha: impact on receptor and effector coupling.
    Lee TW, Seifert R, Guan X, Kobilka BK.
    Biochemistry; 1999 Oct 19; 38(42):13801-9. PubMed ID: 10529225
    [Abstract] [Full Text] [Related]

  • 8. Facilitation of signal onset and termination by adenylyl cyclase.
    Scholich K, Mullenix JB, Wittpoth C, Poppleton HM, Pierre SC, Lindorfer MA, Garrison JC, Patel TB.
    Science; 1999 Feb 26; 283(5406):1328-31. PubMed ID: 10037603
    [Abstract] [Full Text] [Related]

  • 9. Monovalent anions differentially modulate coupling of the beta2-adrenoceptor to G(s)alpha splice variants.
    Seifert R.
    J Pharmacol Exp Ther; 2001 Aug 26; 298(2):840-7. PubMed ID: 11454950
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants.
    Wenzel-Seifert K, Liu HY, Seifert R.
    Biochem Pharmacol; 2002 Jul 01; 64(1):9-20. PubMed ID: 12106601
    [Abstract] [Full Text] [Related]

  • 13. Crystal structure of the adenylyl cyclase activator Gsalpha.
    Sunahara RK, Tesmer JJ, Gilman AG, Sprang SR.
    Science; 1997 Dec 12; 278(5345):1943-7. PubMed ID: 9395396
    [Abstract] [Full Text] [Related]

  • 14. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
    Reinartz MT, Kälble S, Wainer IW, Seifert R.
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May 12; 388(5):517-24. PubMed ID: 25637582
    [Abstract] [Full Text] [Related]

  • 15. Properties of Arg389-beta1-adrenoceptor-Gsalpha fusion proteins: comparison with Gly389-beta1-adrenoceptor-Gsalpha fusion proteins.
    Wenzel-Seifert K, Seifert R.
    Recept Channels; 2003 May 12; 9(5):315-23. PubMed ID: 14527875
    [Abstract] [Full Text] [Related]

  • 16. Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor.
    Reinartz MT, Kälble S, Littmann T, Ozawa T, Dove S, Kaever V, Wainer IW, Seifert R.
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan 12; 388(1):51-65. PubMed ID: 25342094
    [Abstract] [Full Text] [Related]

  • 17. Conditional activation defect of a human Gsalpha mutant.
    Iiri T, Farfel Z, Bourne HR.
    Proc Natl Acad Sci U S A; 1997 May 27; 94(11):5656-61. PubMed ID: 9159128
    [Abstract] [Full Text] [Related]

  • 18. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
    Seifert R, Wenzel-Seifert K, Gether U, Kobilka BK.
    J Pharmacol Exp Ther; 2001 Jun 27; 297(3):1218-26. PubMed ID: 11356949
    [Abstract] [Full Text] [Related]

  • 19. Co-expression of the beta2-adrenoceptor and dopamine D1-receptor with Gsalpha proteins in Sf9 insect cells: limitations in comparison with fusion proteins.
    Gille A, Seifert R.
    Biochim Biophys Acta; 2003 Jun 27; 1613(1-2):101-14. PubMed ID: 12832091
    [Abstract] [Full Text] [Related]

  • 20. Stable association of G proteins with beta 2AR is independent of the state of receptor activation.
    Lachance M, Ethier N, Wolbring G, Schnetkamp PP, Hébert TE.
    Cell Signal; 1999 Jul 27; 11(7):523-33. PubMed ID: 10405763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.